Tebao Biotechnology (688278.SH): The clinical trial application for ACT201 injection has received an acceptance notice.

Zhimedia Finance APP News, Tech-Bio (688278.SH) has announced that the company recently received the "Acceptance Notification" issued by the National Medical Products Administration. The company's clinical trial application for ACT201 injection has been accepted.